A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder

Status:
Completed

Trial end date:
2018-11-08

Target enrollment:

Participant gender:

To evaluate the safety, efficacy and tolerability of brexpiprazole (with placebo) as monotherapy or combination therapy (Zoloft) in adults with PTSD.

Phase 2

Otsuka Pharmaceutical Development & Commercialization, Inc.

H. Lundbeck A/S

Brexpiprazole
Sertraline